LA JOLLA PHARMACEUTICAL CO·5

Feb 9, 4:33 PM ET

JENN PAUL 5

5 · LA JOLLA PHARMACEUTICAL CO · Filed Feb 9, 2005

Insider Transaction Report

Form 5
Period: 2004-12-31
JENN PAUL
VP of Product Development
Transactions
  • Other

    Common Stock

    2004-06-30$1.48/sh+349$5161,912 total
  • Other

    Common Stock

    2004-09-30$1.48/sh+295$4362,207 total
  • Other

    Common Stock

    2004-12-31$1.42/sh+361$5122,568 total
Holdings
  • Common Stock

    2,568
  • Stock Option (right to buy)

    Common Stock (409,474 underlying)
    409,474
Footnotes (2)
  • [F1]Acquired pursuant to the Company?s Employee Stock Purchase Plan.
  • [F2]Reporting only direct holdings, no transaction data is necessary

Documents

2 files
  • 5
    doc5.xmlPrimary

    FORM 5 SUBMISSION

  • EX-24.5_72147

    POA DOCUMENT